CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance

Delayed diagnosis of ovarian cancer, as well as high recurrence rates and lack of personalized therapy options, are among the causes for poor survival figures. Much effort is made towards developing new therapeutic possibilities, however predictive biomarkers are still unavailable. CCNE1 amplificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapoznik, Stav, Aviel-Ronen, Sarit, Bahar-Shany, Keren, Zadok, Oranit, Levanon, Keren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617501/
https://www.ncbi.nlm.nih.gov/pubmed/28977941
http://dx.doi.org/10.18632/oncotarget.19272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617501/
https://www.ncbi.nlm.nih.gov/pubmed/28977941
http://dx.doi.org/10.18632/oncotarget.19272

Ejemplares similares